BAMYXIN

This brand name is authorized in Israel.

Active ingredients

The drug BAMYXIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Polymyxin B UNII 19371312D4 - POLYMYXIN B SULFATE
	Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane.
	Read more about Polymyxin B
2	Bacitracin UNII 58H6RWO52I - BACITRACIN
	Read more about Bacitracin
3	Neomycin UNII 057Y626693 - NEOMYCIN SULFATE
	Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.
	Read more about Neomycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AA20	Antibiotics in combination with other drugs	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
IL	מִשְׂרַד הַבְּרִיאוּת	1470